Clinical guideline for moderate-to-severe ulcerative colitis released
The American Gastroenterological Association (AGA) has released a new clinical guideline on the pharmacological management of ...
clinicaladvisor.com1d
Bimzelx Approved for Moderate to Severe Hidradenitis Suppurativa
The Food and Drug Administration (FDA) has approved Bimzelx ® (bimekizumab-bkzx) for the treatment of moderate to severe hidradenitis suppurativa (HS) in adults.
Monthly Prescribing Reference1mon
Botox Cosmetic Approved for Moderate to Severe Platysma Bands
In both phase 3 trials, onabotulinumtoxinA significantly improved platysma band severity at maximum contraction compared with placebo. The Food and Drug Administration (FDA) has approved Botox ...
Pacira Announces 104-Week Safety and Efficacy Data Following Local Administration of PCRX-201 for Moderate to Severe Osteoarthritis of the Knee
Participants were broken into two cohorts. The first cohort received one of three doses of PCRX-201. The second cohort received concurrent pretreatment with an intraarticular corticosteroid ...
clinicaladvisor.com1mon
Botox Cosmetic Approved for Moderate to Severe Platysma Bands
The Food and Drug Administration (FDA) has approved Botox ® Cosmetic (onabotulinumtoxinA) for the temporary improvement in the appearance of moderate to severe platysma bands associated with ...